Atlas Trials

Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes

Clinical trial NCT05743868 · RECRUITING

Trial details

NCT number
NCT05743868
Sponsor
Yale University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Insulin ResistanceHypertriglyceridemia
Start date
2023-11-16
Primary completion
2026-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.